|
Stem and progenitor cell alterations in myelodysplastic syndromes
|
Feb 2017
|
Blood
|
myelodysplastic syndromes (MDS)
|
|
Statin Use in Myelodysplastic Syndromes Is Associated with a Better Survival and Decreased Progression to Leukemia
|
Apr 2023
|
Blood Advances
|
myelodysplastic syndromes (MDS)
|
|
STAT3-mutations indicate the presence of subclinical T cell clones in a subset of aplastic anemia and myelodysplastic syndrome patients.
|
Aug 2013
|
Blood
|
aplastic anemia
|
|
Standardizing the Initial Evaluation for Myelodysplastic Syndromes.
|
Nov 2013
|
Curr Hematol
|
myelodysplastic syndromes (MDS)
|
|
Standardized High-Sensitivity Flow Cytometry Testing for Paroxysmal Nocturnal Hemoglobinuria in Children with Acquired Bone Marrow Failure Disorders: A Single Center U.S. Study
|
Jun 2017
|
Cytometry B Clin Cytom
|
paroxysmal nocturnal hemoglobinuria (PNH)
|
|
Standardization of flow cytometry in myelodysplastic syndromes: a report from an international consortium and the European LeukemiaNet Working Group
|
Feb 2012
|
Leukemia
|
myelodysplastic syndromes (MDS)
|
|
Spontaneous remision of aplastic anemia occurring during a pregnancy
|
Aug 2012
|
Ann Biol Clin (Paris)
|
aplastic anemia
|
|
Splicing factor mutations in myelodysplasia
|
Oct 2012
|
Int J Hematol
|
myelodysplastic syndromes (MDS)
|
|
Specific Plasma Autoantibody Reactivity in Myelodysplastic Syndromes
|
Nov 2013
|
Sci Rep
|
myelodysplastic syndromes (MDS)
|
|
Specific abnormalities versus number of abnormalities and cytogenetic scoring systems for outcome prediction after allogeneic hematopoietic SCT for myelodysplastic syndromes
|
May 2014
|
Bone Marrow Transplant
|
myelodysplastic syndromes (MDS)
|
